Beyond Air Inc (XAIR) Stock Price, Quote & News

Company Profile

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiol...

Industry: Medical Devices

Sector: Healthcare

Phone: 516-665-8200

Website: www.beyondair.net

Address:

900 Stewart Avenue, Suite 301, Garden City, United States

flyinFish Jul. 16 at 10:09 PM

$XAIR that's about the silliest thing I've ever read, anybody that thinks this dog is going to jump through hoops anytime soon is either high or just plain dumb.. I say move on save your money for something else. Horrible business plan & horrible results are the only thing that seem to demonstrate any consisteny. Fail!

1 · Reply

El_Grande_Sniper Jul. 16 at 7:55 PM

$XAIR I'm loaded ready for action! 💲💲💲😋😋😋

0 · Reply

El_Grande_Sniper Jul. 16 at 7:09 PM

$XAIR Looks like pump incoming, maybe $10+

0 · Reply

Steiner75 Jul. 16 at 3:38 PM

$XAIR Looking strong on MASSIVE volume today.

0 · Reply

finshort Jul. 15 at 7:40 PM

$SPY $QQQ —> $XAIR cost to borrow rate spiked today to over 50%. The rate is now 109% above the 30-day average. https://finshort.com/XAIR

0 · Reply

Steiner75 Jul. 15 at 4:40 PM

$XAIR beastmode today 💪 Going to $100 by eow

0 · Reply

Richard_Roma Jul. 15 at 11:42 AM

$XAIR but they were going to cure cancer! 🤪

0 · Reply

VernCapital Jul. 14 at 6:25 PM

$XAIR well the R/S is going well. Who knew that doing 2 R/S in a year would be bad 🤷🏻‍♂️😂

1 · Reply

Say_Whaaaat Jul. 14 at 6:23 PM

$XAIR

0 · Reply

LQQKER_INSIDER Jul. 14 at 5:52 PM

$XAIR COOL! For every $1.X peeps lend them, they lose $88.26. What a GREAT business model! Management must believe that they have the BEST (not smartest) shareholders! 🏆

0 · Reply

Beyond Air trading halted, news pending

Jun 26, 2026, 8:00 AM EDT - 22 days ago

Beyond Air Earnings Call Transcript: Q4 2026

Jun 26, 2026, 8:00 AM EDT - 22 days ago

Beyond Air Earnings release: Q4 2026

Jun 26, 2026, 8:00 AM EDT - 22 days ago

Beyond Air Annual report: Q4 2026

2026-06-26T11:20:47.000Z - 22 days ago

Beyond Air narrows FY26 revenue view to $8M from $8M-$10M, consensus $8.08M

2026-06-26T11:20:37.000Z - 22 days ago

Beyond Air sees FY27 revenue $16M-$18M, consensus $12.7M

2026-06-26T11:15:15.000Z - 22 days ago

Beyond Air reports Q4 EPS (77c) vs. ($1.79) last year

Jun 26, 2026, 7:00 AM EDT - 22 days ago

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

Jun 22, 2026, 4:01 PM EDT - 25 days ago

Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast

Jun 10, 2026, 8:00 AM EDT - 5 weeks ago

Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting

2026-06-01T13:58:00.000Z - 6 weeks ago

Beyond Air receives Nasdaq hearing panel decision granting continued listing

Jun 1, 2026, 8:00 AM EDT - 6 weeks ago

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

May 5, 2026, 8:00 AM EDT - 2 months ago

Beyond Air Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Beyond Air Proxy statement: Proxy filing

2026-04-20T12:58:40.000Z - 3 months ago

Beyond Air’s Beyond Cancer reports updated data from Phase 1 UNO trial

Apr 20, 2026, 8:00 AM EDT - 3 months ago

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Apr 15, 2026, 8:00 AM EDT - 3 months ago

Beyond Air to Participate in the D. Boral Capital Global Conference 2026

2026-03-26T20:10:58.000Z - 4 months ago

Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds

2026-03-17T20:45:51.000Z - 4 months ago

Beyond Air subsidiary reports signs of clinical activity from UNO trial

Mar 17, 2026, 4:35 PM EDT - 4 months ago

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

Mar 12, 2026, 2:30 PM EDT - 4 months ago

Beyond Air Transcript: Life Sciences Virtual Investor Forum

2026-03-10T11:35:43.000Z - 4 months ago

Beyond Air announces termination of NeuroNOS agreement with XTL

XTLB

2026-02-20T13:08:00.000Z - 5 months ago

Beyond Air announces publication of review article on effects of iNO

Feb 20, 2026, 8:00 AM EST - 5 months ago

Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

2026-02-19T21:31:02.000Z - 5 months ago

Beyond Air price target lowered to $2 from $6 at JonesResearch

Feb 13, 2026, 8:00 AM EST - 5 months ago

Beyond Air Earnings Call Transcript: Q3 2026

Feb 13, 2026, 8:00 AM EST - 5 months ago

Beyond Air Earnings release: Q3 2026

Feb 13, 2026, 8:00 AM EST - 5 months ago

Beyond Air Quarterly report: Q3 2026

2026-02-13T12:36:07.000Z - 5 months ago

Beyond Air reports Q3 EPS (85c) vs ($2.96) last year

2026-02-13T12:36:01.000Z - 5 months ago

Beyond Air sees FY26 revenue $8M-$10M, consensus $8.28M

Feb 13, 2026, 7:30 AM EST - 5 months ago

Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Feb 13, 2026, 6:00 AM EST - 5 months ago

Beyond Air Slides: Corporate presentation

2026-01-30T21:10:38.000Z - 6 months ago

Beyond Air files to sell 7.86M shares of common stock for holders

Jan 30, 2026, 7:00 AM EST - 6 months ago

Beyond Air Registration statement: Registration Filing

2026-01-29T21:40:19.000Z - 6 months ago

XTL Biopharmaceuticals provides update on recent developments

XTLB

Jan 27, 2026, 4:05 PM EST - 6 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

2026-01-20T12:35:20.000Z - 6 months ago

Beyond Air initiated with a Buy at Rodman & Renshaw

Jan 15, 2026, 1:30 PM EST - 6 months ago

Beyond Air Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

Jan 13, 2026, 7:30 AM EST - 6 months ago

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Dec 19, 2025, 7:00 AM EST - 7 months ago

Beyond Air Proxy statement: Proxy Filing

Dec 11, 2025, 7:00 AM EST - 7 months ago

Beyond Air Registration statement: Registration Filing

Nov 26, 2025, 4:30 PM EST - 8 months ago

Beyond Air® Announces Transition of Chief Financial Officer

Nov 21, 2025, 7:00 AM EST - 8 months ago

Beyond Air Registration statement: Registration Filing

Nov 10, 2025, 4:30 PM EST - 8 months ago

Beyond Air Earnings Call Transcript: Q2 2026

Nov 10, 2025, 4:30 PM EST - 8 months ago

Beyond Air Quarterly report: Q2 2026

Nov 10, 2025, 4:30 PM EST - 8 months ago

Beyond Air Earnings release: Q2 2026

Nov 10, 2025, 4:05 PM EST - 8 months ago

Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:00 AM EST - 8 months ago

Beyond Air Slides: Corporate presentation

Sep 30, 2025, 8:00 AM EDT - 10 months ago

Beyond Air Registration statement: Registration Filing

Sep 25, 2025, 8:00 AM EDT - 10 months ago

Beyond Air Registration statement: Registration Filing

Sep 22, 2025, 8:00 AM EDT - 10 months ago

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Sep 8, 2025, 3:55 PM EDT - 11 months ago

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Sep 3, 2025, 8:00 AM EDT - 11 months ago

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 8:00 AM EDT - 11 months ago

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings Call Transcript: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings release: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Quarterly report: Q1 2026

Jul 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Jul 22, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings Call Transcript: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Annual report: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings release: Q4 2025

Jun 17, 2025, 4:01 PM EDT - 1 year ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Jun 16, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

May 20, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

May 5, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Apr 21, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Apr 15, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Apr 9, 2025, 4:05 PM EDT - 1 year ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Mar 11, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings release: Q3 2025

Feb 10, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Feb 5, 2025, 9:29 AM EST - 1 year ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Jan 31, 2025, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Jan 27, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Jan 24, 2025, 9:15 AM EST - 1 year ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Jan 13, 2025, 10:30 AM EST - 1 year ago

Beyond Air Transcript: Lytham Partners 2025 Investor Healthcare Summit

Dec 9, 2024, 11:00 AM EST - 1 year ago

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Dec 4, 2024, 4:30 PM EST - 1 year ago

Beyond Air Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 3, 2024, 4:05 PM EST - 1 year ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Dec 2, 2024, 7:30 AM EST - 1 year ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

Nov 26, 2024, 7:30 AM EST - 1 year ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Nov 21, 2024, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Nov 14, 2024, 4:05 PM EST - 1 year ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q2 2025

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q2 2025

Nov 11, 2024, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Oct 29, 2024, 4:22 PM EDT - 1 year ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Oct 25, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Registration statement: Registration Filing

Oct 18, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Oct 7, 2024, 7:00 AM EDT - 1 year ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 2, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Sep 27, 2024, 7:34 AM EDT - 1 year ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Sep 27, 2024, 7:32 AM EDT - 1 year ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Sep 27, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Aug 20, 2024, 8:00 AM EDT - 2 years ago

Beyond Air Registration statement: Registration Filing

Aug 6, 2024, 4:00 PM EDT - 2 years ago

Beyond Air Quarterly report: Q1 2025

Aug 6, 2024, 4:00 PM EDT - 2 years ago

Beyond Air Earnings release: Q1 2025

Jul 31, 2024, 4:15 PM EDT - 2 years ago

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Jul 23, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Jul 16, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Earnings Call Transcript: Q4 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Earnings release: Q4 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Annual report: Q4 2024

Jun 24, 2024, 4:15 PM EDT - 2 years ago

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Jun 13, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® Appoints David Webster as Chief Commercial Officer

flyinFish Jul. 16 at 10:09 PM

1 · Reply

El_Grande_Sniper Jul. 16 at 7:55 PM

$XAIR I'm loaded ready for action! 💲💲💲😋😋😋

0 · Reply

El_Grande_Sniper Jul. 16 at 7:09 PM

$XAIR Looks like pump incoming, maybe $10+

0 · Reply

Steiner75 Jul. 16 at 3:38 PM

$XAIR Looking strong on MASSIVE volume today.

0 · Reply

finshort Jul. 15 at 7:40 PM

$SPY $QQQ —> $XAIR cost to borrow rate spiked today to over 50%. The rate is now 109% above the 30-day average. https://finshort.com/XAIR

0 · Reply

Steiner75 Jul. 15 at 4:40 PM

$XAIR beastmode today 💪 Going to $100 by eow

0 · Reply

Richard_Roma Jul. 15 at 11:42 AM

$XAIR but they were going to cure cancer! 🤪

0 · Reply

VernCapital Jul. 14 at 6:25 PM

$XAIR well the R/S is going well. Who knew that doing 2 R/S in a year would be bad 🤷🏻‍♂️😂

1 · Reply

Say_Whaaaat Jul. 14 at 6:23 PM

$XAIR

0 · Reply

LQQKER_INSIDER Jul. 14 at 5:52 PM

$XAIR COOL! For every $1.X peeps lend them, they lose $88.26. What a GREAT business model! Management must believe that they have the BEST (not smartest) shareholders! 🏆

0 · Reply

uptrend2025 Jul. 14 at 5:46 PM

$XAIR 😮. Not ready yet.

1 · Reply

Say_Whaaaat Jul. 14 at 2:14 PM

$XAIR this is on track to delist next week already! Down 10% yesterday and so far 15% today.

0 · Reply

TwongStocks Jul. 13 at 8:23 PM

Today's reverse split results. Only 1 of 8 closed green today. Part 2 of 2: $FTFT 1 for 4 Previous close $0.4967, $1.9868 split-adjusted Today's high $2.17 (premarket) Today's close $1.83 🔴Down 7.89% $LMFA 1 for 25 Previous close $0.1321, $3.3025 split-adjusted Today's high $3.65 (premarket) Today's close $2.92 🔴Down 11.58% $XAIR 1 for 20 Previous close $0.4170, $8.34 split-adjusted Today's high $8.19 Today's close $7.49 🔴Down 10.19% $YHC 1 for 100 Previous close $0.0241, $2.41 split-adjusted Today's high $2.72 Today's close $2.57 🟢Up 6.64%

1 · Reply

VernCapital Jul. 13 at 4:11 PM

$XAIR I sure miss the days when our shares were $6000 each 🙄

1 · Reply

TwongStocks Jul. 13 at 12:04 PM

$FTFT $LMFA $XAIR $YHC are among the 8 NASDAQ stocks with reverse splits today. Full details in the quoted post. Trading resumes at 9:00am ET with the RS in effect.

1 · Reply

TwongStocks Jul. 10 at 10:34 PM

Eight NASDAQ stocks with reverse splits on Monday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Monday morning. Will split this into two parts. Part 2 of 2: $FTFT 1 for 4. Will reduce outstanding shares from approx 7.47m to approx 1.87m. $LMFA 1 for 25. Will reduce outstanding shares from approx 17.35m to approx 694k. $XAIR 1 for 20. Will reduce outstanding shares from approx 14.41m to approx 721k. $YHC 1 for 100. Will reduce outstanding shares from approx 130.38m to approx 1.30m.

0 · Reply

TwongStocks Jul. 9 at 5:36 PM

$XAIR Equity Corporate Actions Alert #2026 - 486 Information Regarding the Reverse Stock Split and CUSIP Number Change for Beyond Air, Inc. (XAIR) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-486 Beyond Air, Inc. (XAIR) will effect a one-for-twenty (1-20) reverse split of its common stock. The reverse stock split will become effective on Monday, July 13, 2026. In conjunction with the reverse split, the CUSIP number will change to 08862L301.

0 · Reply

Say_Whaaaat Jul. 9 at 4:45 PM

$XAIR there's only going to be 720k shares give or take. Think this tanks right out or squeezes up?

1 · Reply

domarffm Jul. 9 at 1:37 PM

$XAIR Reverse Split with 1:20 confirmed for next Monday https://s3.amazonaws.com/sec.irpass.cc/2690/0001493152-26-032621.htm

0 · Reply

Say_Whaaaat Jul. 9 at 1:30 PM

$XAIR RS incoming Monday the 13th

0 · Reply

uptrend2025 Jul. 6 at 3:22 PM

$XAIR when is the RS deadline? Waiting to jump in after RS.

2 · Reply

VernCapital Jun. 30 at 1:44 PM

$XAIR will probably R/S closer to deadline to ensure it doesn’t get beaten down

2 · Reply

Market Cap	4.00M
Revenue (ttm)	7.68M
Net Income (ttm)	-33.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-432.94%
Debt to Equity Ratio	3.55

Volume	15,500
Avg Vol	16,504
Day's Range	N/A - N/A
Shares Out	721,000.00
Stochastic %K	7%
Beta	0.22
Analysts	Sell
Price Target	$40.00